Live Breaking News & Updates on மெர்லயன் மருந்துகள்
Stay updated with breaking news from மெர்லயன் மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Plant Derivative Drugs Market is Expected to Reach USD 502.4 & Grow at a CAGR of 2.60% Forecast to 2 pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
MerLion Pharmaceuticals Completes Growth Financing Round 05/18/2021 | 03:30am EDT Send by mail : Message : TM Berlin, (18/05/2021) - MerLion Pharmaceuticals GmbH (MerLion), a biopharmaceutical company focused on research and development of novel antibiotics for the treatment of serious bacterial infections, today announced the successful completion of a growth financing round raised via a private placement to European strategic investors. The funds raised will primarily be used to finance the production and market launch of MerLion’s US FDA and Health Canada approved drug Xtoro TM, an otic suspension containing finafloxacin for treatment of ear infections. In addition to existing investors such as HeidelbergCapital and Vl Partners, new strategic investors such as Denk Pharma GmbH & Co. KG have taken part in the round. Further details were not disclosed. ....
Share this article Share this article ResearchAndMarkets.com s offering. Antimicrobial Resistance is creating new kinds of infections and superbugs that are resistant to current antibiotic medicines. New technologies (and new drugs) are under development to capture this growing market. We have identified the 6 Key Large Opportunities in this space and developed market forecasts.The publisher has looked at the technology picture too, giving you, plain language understanding of the different ways pathogens, and infections, can be treated, including an explanation of the key role diagnostics will play. This is a market with a lot of players, there are over 100 biotechnology companies profiled in the report. And the publisher summarizes what technologies they are using. ....